Guangdong VTR Bio-Tech Co Ltd
SZSE:300381

Watchlist Manager
Guangdong VTR Bio-Tech Co Ltd Logo
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
Watchlist
Price: 7.13 CNY -1.11% Market Closed
Market Cap: ¥3.5B

Profitability Summary

Guangdong VTR Bio-Tech Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Guangdong VTR Bio-Tech Co Ltd

Margins Comparison
Guangdong VTR Bio-Tech Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
3.5B CNY
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.5B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Guangdong VTR Bio-Tech Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
3.5B CNY
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.5B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Guangdong VTR Bio-Tech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate